• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Arch Virol . Single-particle quantification of SARS-CoV-2 virus-like particles using flow virometry

tetano

Editor, Senior Moderator
Arch Virol


. 2025 Jun 7;170(7):149.
doi: 10.1007/s00705-025-06339-w. Single-particle quantification of SARS-CoV-2 virus-like particles using flow virometry

Hyeop Jin[SUP] 1 [/SUP], Ye Rae Cho[SUP] 1 [/SUP], Yong Tae Jung[SUP] 2 [/SUP]



Affiliations
Abstract

SARS-CoV-2 virus-like particles (VLPs) were generated by co-transfecting HEK 293T cells with four plasmids, two for expression of the spike (S) or nucleocapsid (N) protein with a 3xHA tag at the C-terminus, one for expression of the membrane (M) protein, and one for expression of the envelope (E) protein. Co-localization of the S and N proteins within the VLPs was confirmed by Western blot analysis using anti-HA antibodies. To enable fluorescent quantification of VLPs, the C-terminus of the S protein was fused to enhanced green fluorescent protein (EGFP), and the N protein was tagged with EGFP at either the N- or C-terminus. Transient transfection of 293T cells with (S-GFP)NME, S(N-GFP)ME, or S(GFP-N)ME plasmids efficiently produced fluorescent VLPs, each demonstrating the ability to enter A549-hACE2 cells. In addition, a two-plasmid system was developed to simplify fluorescent VLP production by incorporating internal ribosomal entry site elements between N3xHA and S-GFP and between the M and E genes. Transfection of 293T cells with these plasmids produced VLPs with a fourfold higher N protein concentration (800 ng/mL) compared to the four-plasmid system (200 ng/mL), as measured by ELISA. Flow virometry analysis confirmed production of VLPs with an average diameter of 80 nm and a concentration of 1.68 × 10[SUP]8[/SUP] particles/ml. This study demonstrates that production of fluorescent VLPs using a two-plasmid system is more efficient than the traditional four-plasmid approach. We also demonstrate that flow virometry is a robust method for single-particle analysis of fluorescent VLPs for determining their size and concentration.


 
Back
Top Bottom